Literature DB >> 23668992

Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.

Nikolaos P Polyzos1, Herman Tournaye, Luis Guzman, Michel Camus, Scott M Nelson.   

Abstract

OBJECTIVE: To identify predictors of ovarian response in women undergoing ovarian stimulation with corifollitropin alfa in a GnRH antagonist protocol and determine specific thresholds for the prediction of low and excessive responders.
DESIGN: Retrospective cohort study.
SETTING: University-based tertiary care center. PATIENT(S): Infertile women undergoing ovarian stimulation for in vitro fertilization/intracytoplasmic sperm injection. INTERVENTION(S): Controlled ovarian hyperstimulation with corifollitropin alfa in a GnRH antagonist protocol. MAIN OUTCOME MEASURE(S): Relationship between ovarian reserve tests and ovarian response. RESULT(S): Antimüllerian hormone (AMH) and antral follicle count (AFC) were the only independent predictors for low and excessive ovarian response. In prediction of excessive response, the area under the receiver operating characteristic curve [AUC (95% CI)] for AMH was 0.890 (0.832-0.947) and 0.897 (0.829-0.964) for AFC. The optimal thresholds for identifying excessive responders were 3.52 ng/mL for AMH (sensitivity 89.5, specificity 83.8) and 16 for AFC (sensitivity 80.0, specificity 84.5). AMH and AFC also predicted low ovarian response: AUCs AMH 0.836 (0.783-0.889) and AFC 0.830 (0.767-0.894). The optimal thresholds for predicting low response were 1.37 ng/mL for AMH (sensitivity 74.1, specificity 77.5) and 8 for AFC (sensitivity 72.2, specificity 84.6). For both excessive and low ovarian responses, a logistic regression model combining the biomarkers was associated with improved discrimination. CONCLUSION(S): AMH and AFC are the best predictors for low and excessive response in women treated with corifollitropin alfa in an antagonist protocol. Using AMH and AFC to select suitable candidates for treatment with corifollitropin alfa may result in a safe and convenient stimulation.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AFC; AMH; Corifollitropin alfa; OHSS; antimüllerian hormone; poor responders

Mesh:

Substances:

Year:  2013        PMID: 23668992     DOI: 10.1016/j.fertnstert.2013.04.029

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  10 in total

1.  An update on the prevention of ovarian hyperstimulation syndrome.

Authors:  Omar El Tokhy; Julia Kopeika; Tarek El-Toukhy
Journal:  Womens Health (Lond)       Date:  2016-08-19

2.  Are ovarian response and pregnancy rates similar in selected FMR1 premutated and mutated patients undergoing preimplantation genetic testing?

Authors:  Noemie Ranisavljevic; Mathilde Hess; Christel Castelli; Marjolene Willems; Alice Ferrieres-Hoa; Anne Girardet; Tal Anahory
Journal:  J Assist Reprod Genet       Date:  2020-06-02       Impact factor: 3.412

3.  Association of progesterone production with serum anti-Müllerian hormone levels in assisted reproductive technology cycles with corifollitropin alfa.

Authors:  Tsung-Hsien Lee; Shu-Ling Tzeng; Chun-I Lee; Hsiu-Hui Chen; Chun-Chia Huang; Shee-Uan Chen; Maw-Sheng Lee
Journal:  PLoS One       Date:  2018-11-14       Impact factor: 3.240

4.  Fixed versus flexible antagonist protocol in women with predicted high ovarian response except PCOS: a randomized controlled trial.

Authors:  Xiu Luo; Li Pei; Fujie Li; Chunli Li; Guoning Huang; Hong Ye
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-02       Impact factor: 3.105

5.  Efficacy of three COS protocols and predictability of AMH and AFC in women with discordant ovarian reserve markers: a retrospective study on 19,239 patients.

Authors:  Yaxin Guo; Huahua Jiang; Shiqiao Hu; Shuai Liu; Fei Li; Lei Jin
Journal:  J Ovarian Res       Date:  2021-08-28       Impact factor: 4.234

6.  What is the value of anti-Müllerian hormone in predicting the response to ovarian stimulation with GnRH agonist and antagonist protocols?

Authors:  Jure Knez; Borut Kovačič; Maruška Medved; Veljko Vlaisavljević
Journal:  Reprod Biol Endocrinol       Date:  2015-06-10       Impact factor: 5.211

7.  Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.

Authors:  Sergio Oehninger; Scott M Nelson; Pierre Verweij; Barbara J Stegmann
Journal:  Reprod Biol Endocrinol       Date:  2015-10-31       Impact factor: 5.211

8.  Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study.

Authors:  Gorka Barrenetxea; Juan Antonio García-Velasco; Belén Aragón; Jordi Osset; Max Brosa; Noemí López-Martínez; Buenaventura Coroleu
Journal:  Reprod Biomed Soc Online       Date:  2018-02-21

9.  Searching for female reproductive aging and longevity biomarkers.

Authors:  Svetlana Yureneva; Viktoriya Averkova; Denis Silachev; Andrey Donnikov; Alla Gavisova; Vladimir Serov; Gennady Sukhikh
Journal:  Aging (Albany NY)       Date:  2021-06-22       Impact factor: 5.682

10.  Development and Validation of Prediction Model for High Ovarian Response in In Vitro Fertilization-Embryo Transfer: A Longitudinal Study.

Authors:  Xinsha Tan; Honglin Xi; Jing Yang; Wenfeng Wang
Journal:  Comput Math Methods Med       Date:  2021-10-16       Impact factor: 2.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.